Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LNW

Light & Wonder Inc. Reports Increase in CDIs and Common Stock on ASX

Light & Wonder Inc. (ASX: LNW) has reported its Appendix 4A Statement of CDIs on issue for the month of March 2025, revealing significant changes in the number of CDIs and other securities on issue compared to the previous month.

The total number of CDIs quoted on ASX at the end of March 2025 was 26,457,647, representing an increase of 72,681 CDIs from the previous month. This net difference is attributed to net transfers of securities between CDIs and Common Stock as quoted or held on NASDAQ.

Additionally, the total number of securities not represented by CDIs quoted on ASX, specifically Common Stock, stood at 58,626,583 at the end of March 2025, reflecting a net increase of 629,422 securities compared to the previous month. This change is primarily due to the transfer of Common Shares to CDIs, a decrease in Common Shares repurchased by the issuer's ongoing share repurchase program offset by an increase in total shares outstanding pursuant to the vesting of the issuer's outstanding RSUs and the exercise of previously issued options to Common Shares.

These figures indicate a notable shift in the composition of securities on issue for Light & Wonder Inc., highlighting the dynamics of its CDIs and other securities over the reporting period. Today the company's shares have moved -3.8% to a price of $80.62. For the full picture, make sure to review Light & Wonder's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS